Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. HPQ
9. NTNX
10. SPY

Go back to Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 4.05 -0.12 (2.88%)
Previous Close $4.17    52 Week High $ 
Open $4.16    52 Week Low $ 
Day High $4.16    P/E N/A 
Day Low $4.02    EPS $ 
Volume 673,589